Close Menu

NEW YORK (GenomeWeb) – San Diego-based Diagnomics will begin offering comprehensive and customized pharmacogenetic test reports through a strategic partnership with Translational Software.  

The PGx analysis will be performed on Illumina's Global Screening Array and a comprehensive report on how the detected markers are likely to impact the patient's drug response, metabolism, and treatment efficacy will be generated using Translational Software's platform.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

Sponsored by
LGC SeraCare Life Sciences

As we pass the one-year anniversary of both the COVID-19 pandemic and the first Emergency Use Authorized SARS-CoV-2 PCR detection assays, there remains significant opportunity for clinical laboratories to advance testing and support improved patient management.

Sponsored by

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.